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Abstract: 
22q11.2 Deletion Syndrome (22q11DS) is the most common genetic microdeletion syndrome 
affecting humans. The syndrome is associated with general cognitive impairments and specific 
deficits in visual-spatial ability, non-verbal reasoning, and planning skills. 22q11DS is also 
associated with behavioral and psychiatric abnormalities, including a markedly elevated risk for 
schizophrenia. Research findings indicate that people with schizophrenia, as well as those 
identified as schizoptypic, show specific cognitive deficits in the areas of sustained attention, 
executive functioning, and verbal working memory. The present study examined such 
schizophrenic-like cognitive deficits in children and adolescents with 22q11DS (n = 26) and 
controls (n = 25) using a cross-sectional design. As hypothesized, 22q11DS participants 
exhibited deficits in intelligence, achievement, sustained attention, executive functioning, and 
verbal working memory compared to controls. Furthermore, deficits in attention and executive 
functioning were more pronounced in the 22q11DS sample relative to general cognitive 
impairment. These findings suggest that the same pattern of neuropsychological impairment seen 
in patients with schizophrenia is present in non-psychotic children identified as at-risk for the 
development of schizophrenia based on a known genetic risk marker. © 2006 Wiley-Liss, Inc. 
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Article: 
 
INTRODUCTION 
The present study examined the relationship between Chromosome 22q11.2 Deletion Syndrome 
(22q11DS) and schizophrenic-like neurocognitive deficits in children and adolescents. 
Retrospective studies suggest that the syndrome is strongly associated with the occurrence of 
psychotic disorders in adulthood [Pulver et al., 1994; Papolos et al., 1996; Bassett et al., 1998; 
Murphy et al., 1999], and thus, represents a promising point of entry for the study of 
schizophrenia in a genetic high-risk sample. It is hypothesized that non-psychotic children and 
adolescents with 22q11DS will exhibit neurocognitive impairment consistent with deficits 
demonstrated by patients with schizophrenia. 
 
22q11 DELETION SYNDROME 
22q11DS, also referred to as DiGeorge Syndrome or Velo-Cardio-Facial Syndrome (VCFS), is 
the result of a hemizygous deletion at band 11.2 on the long arm of chromosome 22 
[Shprintzen, 2000]. A variety of medical, cognitive, and psychosocial deficits have been 
associated with the condition [Bassett and Chow, 1999; Gerdes et al., 1999; Murphy et al., 1999; 
Shprintzen, 2000; Swillen et al., 2000; Bearden et al., 2004; van Amelsvoort et al., 2004; 
Zinkstok and vanAmelsvoort, 2005]. Cognitive deficits include learning disabilities and mild 
mental retardation [Eliez et al., 2000; Swillen et al., 2000; Bearden et al., 2001], and non-verbal 
learning deficits [Rourke, 1995; Swillen et al., 1999; Bearden et al., 2001]. 
 
22q11 Deletion Syndrome and Schizophrenia 
 
Retrospective findings have linked 22q11DS with a markedly elevated rate of psychotic 
disorders such as schizophrenia and bipolar disorder [e.g., Papolos et al., 1996; Gothelf et 
al., 1997; Bassett et al., 1998; Yan et al., 1998; Bassett and Chow, 1999]. Murphy et al. [1999] 
reported that 24% of their patients with VCFS suffered from schizophrenia, and Pulver et al. 
[1994] reported that 31% of their sample of individuals with 22q11DS met criteria for 
schizophrenia or schizoaffective disorder. These studies suggest that the risk for schizophrenia 
among populations with 22q11DS may be 25–30 times that of the general population. By 
comparison, research has not provided comparable evidence of an elevated risk for schizophrenia 
among individuals with other clearly identified genetic syndromes [Bassett and Chow, 1999]. 
Studies investigating the presence of 22q11 deletions in identified schizophrenic populations 
have yielded rates between 1 and 6 % [Karayiorgou et al., 1995; Yan et al., 1998; Usiskin et 
al., 1999; Horowitz et al., 2005]. These findings represent the strongest link to date between 
vulnerability to schizophrenia and a known genetic anomaly. 
Schizophrenia appears to be best conceptualized as a neurodevelopmental disorder 
[Weinberger, 1987; Vincente and Kennedy, 1997; Andreasen, 1999], the liability for which is 
thought to result from a process of neural dysmaturation that arises in prenatal development and 
culminates in late adolescence and early adulthood [Andreasen et al., 1999]. This vulnerability 
may be influenced by a variety of factors including genetic inheritance and gene expression, pre- 
and peri-natal complications, and postnatal biopsychosocial stressors. While evidence from twin, 
adoption, and family studies indicates a substantial genetic contribution to this disorder, the 
number of genes responsible, location of these genes, and their modes of transmission are not 
well understood at this time. It is likely that the vulnerability to schizophrenia is influenced by a 
polygenic or oligogenic model of transmission that is further influenced by environmental 
factors. Since recent studies have established the high risk for schizophrenia in individuals with 
the 22q11.2 deletion, this condition may represent an etiologically specific subtype of the 
disorder [Gothelf et al., 1997; Bassett et al., 1998; Bassett and Chow, 1999; Murphy et al., 1999]. 
Alternatively, 22q11DS may provide a more general contribution toward the neuro-
maldevelopment associated with vulnerability to schizophrenia. 
 
COGNITIVE CHARACTERISTICS OF PATIENTS WITH 22qDS 
Cognitive and educational abilities of children and adolescents with 22q11DS show wide 
variation in intelligence with a mean Full-Scale IQ around 70 [Swillen et al., 2000]. Children and 
adolescents with 22q11DS also tend to show a pattern of relative strengths in the areas of word 
knowledge, factual information, and understanding of concrete situations, and pronounced 
deficits in the areas of visual-spatial memory, non-verbal reasoning, and perceptual motor skills 
[Swillen et al., 1999, 2000; Eliez et al., 2000; Zinkstok and vanAmelsvoort,2005]. Individuals 
with 22q11DS continue to show deficits in visuoperceptual skills, problem-solving, and abstract 
reasoning in adulthood [Henry et al., 2002; van Amelsvoort et al., 2004]. 
Recently, interest in specific gene variations within the commonly deleted region in 22q11DS 
has led to findings suggesting that a functional polymorphism in the COMT gene predicts 
cognitive performance. Additionally, similar findings in non-deleted individuals identified as at-
risk for the development of schizophrenia and in non-deleted schizophrenia patients show 
differential cognitive performance as a function of COMT allele variations. These findings 
indicate that patterns of cognitive performance on prefrontally mediated tasks, as well as general 
cognitive decline, may be related to allele variation in COMT [Egan et al., 2001; Bilder et 
al., 2002; Malhotra et al., 2002; Wonodi et al., 2003; Bearden et al., 2004; Gothelf et al., 2005; 
Shashi et al., 2006]. 
 
Relationship Between Cognitive-Behavioral Profiles in 22q11DS and Schizophrenia 
Given the increased risk of schizophrenia in patients with 22q11DS, researchers have begun to 
link many of the biobehavioral and neurocognitive manifestations of these two disorders. 
Although there is evidence of a generalized cognitive deficit in schizophrenia patients [Cornblatt 
and Erlenmeyer-Kimling, 1985; Saykin et al., 1994], many studies have shown deficits in 
specific cognitive domains in persons identified as schizophrenic or schizotypic, as well as in 
first degree relatives of individuals with schizophrenia [Voglmaier et al.,1997; Saykin et 
al., 1991; Seidman et al., 1997]. Individuals with schizophrenia tend to perform worse than 
comparison groups on sustained attention, executive functioning, and verbal working memory 
[e.g., Lenzenweger and Dworkin, 1998]. Additionally, individuals who are psychometrically 
identified as schizotypic show similar deficits in attention, executive functioning, and verbal 
working memory [Lenzenweger and Dworkin, 1998; Erlenmeyer-Kimling, 2000; Erlenmeyer-
Kimling et al., 2000]. The presence of this pattern of cognitive impairment in non-psychotic 
individuals who have been identified as schizotypic indicates that these deficits exist in the 
absence of the effects of medication, hospitalization, or the catastrophic nature of the disorder 
itself, and supports a continuum of cognitive impairment in schizophrenic patients and in 
vulnerable individuals. 
 
GOALS AND HYPOTHESES OF THE PRESENT STUDY 
The goal of the present study was to examine cognitive abilities in non-psychotic children and 
adolescents with 22q11DS using a cross-sectional case-control design. Specifically, the aims of 
this study were to evaluate general cognitive ability in children and adolescents with 22q11DS, 
and functioning in the specific domains of sustained attention, executive functioning, and verbal 
working memory. These domains of functioning were selected because they have been shown to 
be impaired in individuals with schizophrenia, even in premorbid and prodromal stages. 
Furthermore, these deficits are reported in schizotypic individuals and non-psychotic relatives of 
patients with schizophrenia, suggesting that they are promising markers of vulnerability for 
schizophrenia. It is hypothesized that, compared to controls: (a) participants with 22q11DS will 
exhibit deficits in the domains of sustained attention, executive functioning, and verbal working 
memory, (b) consistent with the established literature, participants with 22q11DS will exhibit 
lower IQ and achievement scores, (c) participants with 22q11DS will have increased rates of 
psychopathology, and (d) differences in neurocognitive functioning between the groups will be 
independent of differences in intelligence or diagnosis. 
The purpose of the present study is construct validation as originally defined by Cronbach and 
Meehl [1955]. Based upon the extant literature that children with 22q11DS are at markedly 
elevated risk for developing schizophrenia, we hypothesize that, as a group, they should exhibit 
schizophrenic-like neurocognitive deficits. The value of studying at-risk individuals before they 
enter the age of greatest risk is threefold: it allows us to test hypotheses regarding the presence of 
schizophrenic-like neurocognitive deficits in an at-risk sample, it provides a baseline for 
longitudinal study, and it allows us to assess neurocognitive deficits relatively unaffected by the 
severe consequences of developing a schizophrenia-spectrum disorder. 
 
MATERIALS AND METHODS 
Participants 
The sample consists of 26 patients with 22q11DS recruited through the Department of Genetics 
at Wake Forest University School of Medicine (WFUSM), and 25 control participants selected 
through recruitment within the pediatric medical genetics and general pediatrics clinics at 
WFUSM, as well as from area pediatric clinics and schools. The participants in the two groups 
were matched for sex and age (within 6 months). Participants ranged in age from 7 to 16. Groups 
did not differ on age at initial assessment, level of education, ethnicity, or sex. The control group 
exceeded the 22q11DS group on rating of parental social position [Hollingshead, 1957]. 
Chromosomal deletions were confirmed using fluorescence in situ hybridization. Table I presents 
the demographic information for the two groups. Consent was obtained from the parent or legal 
guardian of each participant. 
 
Table I. Demographic Characteristics of 22q11DS and Control Groups 
  22q11DS (n = 26) Controls (n = 25) 
 
a Lower scores on social position indicate higher socioeconomic status. 
* P < 0.01. 
** P < 0.001. 
 
A detailed family history was obtained for each participant. Potential control subjects were 
excluded from the study if there was a psychotic illness in a first degree family member. In the 
22q11DS group, the presence of psychosis in a family member who did not have a 22q11.2 
deletion served as an exclusionary criterion. The occurrence of psychotic illness in a parent 
affected with 22q11DS did not qualify as an exclusionary factor for children with 22q11DS. 
Materials 
Measures evaluating sustained attention, executive functioning, verbal memory, intelligence, and 
achievement were administered to all participants. Sustained attention was assessed using the 
Continuous Performance Test-Identical Pairs and AX Versions [CPT-IP; Cornblatt et al., 1989], 
executive functioning was assessed using the Wisconsin Card Sorting Test [WCST; Heaton et 
al., 1993], and verbal memory was assessed using the California Verbal Learning Test-Children's 
Version [CVLT-C; Delis et al., 1994]. Note that these constructs and measures are consistent 
with the recommendations of the National Institute of Mental Health Measurement and 
Treatment Research to Improve Cognition in Schizophrenia Initiative [NIMH-MATRICS; Kern 
et al., 2004]. 
 
Continuous performance test 
  
Age (years) 9.3 (2.6) 9.7 (2.4) 
Gender 39% female 48% female 
Ethnicity 96% Caucasian/4% African American 96% Caucasian/4% African American 
Social positiona 38.1 (15.6) 25.5 (11.8)* 
Education (years) 2.2 (2.5) 2.9 (2.1) 
Global adjustment 61.7 (10.0) 72.0 (9.7)** 
 
The CPT assesses the ability to focus and sustain attention [Cornblatt et al., 1988; Nuechterlein 
et al., 1998]. Participants were administered four identical pairs conditions and the AX condition 
after receiving instructions and a practice condition. All scores are reported in terms of d′, a 
signal detection index which accounts for response bias. Cornblatt and Erlenmeyer-Kimling 
[1985] found that the CPT-IP was an effective predictor of the development of schizophrenia in a 
genetically at-risk sample. 
 
The Wisconsin card sorting test 
The WCST is widely used to assess executive functioning including planfulness, cognitive 
flexibility, and problem-solving [Chelune and Baer, 1986]. Indices reported in the present study 
are perseverative errors, non-perseverative errors, conceptual level response, and categories 
completed. Standard scores are reported for all indices, with higher scores representing better 
performance. Patients with schizophrenia and individuals presumed to be at risk for 
schizophrenia exhibit deficits on WCST performance [e.g., Goldberg and Weinberger, 1988; 
Gooding et al., 1999]. Additionally, recent findings by Diwadkar et al. [2006] demonstrated that 
adolescent offspring of schizophrenia patients made more perseverative errors on the WCST, 
consistent with Diforio et al. [2000], who also found elevations in perseverative errors on the 
WCST in schizotypal adolescents. 
 
The California verbal learning test-children's version 
The CVLT-C is a test of verbal learning and memory appropriate for children aged 5–16 years. 
Participants are verbally given an original list of items and a distracter list and asked to recall the 
items on repeated trials. The present study focused on three domains: recall, learning strategies, 
and recognition. While there is no literature to date examining the relationship between CVLT-C 
performance and psychosis-proneness in children, patients with schizophrenia exhibit 
impairment on the CVLT, as do adults with schizotypal personality disorder [Bergman et 
al., 1998; Hill et al., 2004]. 
 
Wechsler intelligence scale for children, 3rd edition and Wechsler individual achievement 
Test, 2nd edition 
The WISC-III [Wechsler, 1991] battery consists of 10 scaled subtests that combine to yield a 
Verbal IQ score, a Performance IQ score, and a Full-Scale IQ score. Additionally, 2 extra 
subtests were administered and combined with the 10 basic subtests to yield 4 factor scores: 
Verbal Comprehension, Perceptual Organization, Freedom from Distractibility, and Processing 
Speed. The present study utilized six subtests from the WIAT-II [Wechsler, 2001] to assess 
academic achievement in the domains of Broad Reading, Broad Mathematics, and spelling. 
Scores on the WISC-III and WIAT-II are normed to a mean of 100 and a standard deviation of 
15. 
 
Computerized diagnostic interview schedule for children 
The C-DISC [Shaffer et al., 2000] is a structured interview that was administered to each 
participant's parent or caregiver in order to assess psychopathology in the participant. The C-
DISC is based on the DSM-IV [American Psychological Association, 2001] criteria for 
psychological disorders, and is designed to address specific symptoms that must be evaluated in 
order to determine diagnostic status. The present study assessed Mood Disorders, Anxiety 
Disorders, Psychotic Disorders, Attention Deficit /Hyperactivity Disorder (AD/HD), 
Oppositional-Defiant Disorder, and Conduct Disorder. 
 
Procedure 
Participants were assessed individually at Wake Forest University Baptist Medical Center. The 
neurocognitive measures were administered by trained graduate students in clinical psychology 
under the supervision of a licensed clinical psychologist (T.R.K.). The administration of the 
assessment battery required approximately 4–5 hr, so the testing was broken into two or three 
sessions to minimize the effects of fatigue. Control participants received $50 upon the 
completion of the testing sessions. Additionally, all participants received reports summarizing 
the results of the assessments. 
 
RESULTS 
Sustained Attention, Executive Functioning, and Verbal Working Memory 
Table II presents means, standard deviations, and group comparisons on the CPT, WCST, and 
CVLT-C. The four CPT-IP conditions (Numbers Fast, Numbers Slow, Shapes Fast, and Shapes 
Slow) were found to be highly correlated (coefficient alpha = 0.88). Thus, these four conditions 
were averaged to create a CPT-IP condition. The groups differed on the overall CPT-IP 
condition and the CPT-AX condition, with 22q11DS participants performing significantly worse 
on both tasks. In order to minimize the likelihood of Type I errors, groups were first compared 
on conceptually similar continuous variables from the WCST and CVLT-C using MANOVAs. 
Results indicated that there were significant differences between groups on the WCST, Wilkes' 
Lambda = 0.587, P < 0.001; and CVLT-C, Wilkes' Lambda = 0.545, P < 0.001. Individual t-tests 
were conducted for each of the indices of interest, and revealed that the 22q11DS group 
performed significantly worse than the control group on perseverative errors, non-perseverative 
errors, percent conceptual level response, and categories completed on the WCST. Likewise, the 
22q11DS group performed significantly worse than the control group on most CVLT-C indices, 
including recall for list A1, recall from list A1 to list A5, short delay free recall, short delay cued 
recall, long delay free recall, long delay cued recall, and recognition discriminability. However, 
there were no group differences in Semantic Clustering or Serial Clustering, which represent 
recall strategies. 
 
Table II. Means and Standard Deviations of Neurocognitive Measures by Group 
  22q11DS (n = 26) Control (n = 25) t-test 
  
Continuous performance testa       
 IP version 0.15 (0.29) 0.83 (0.62) −4.71** 
 AX version 1.04 (1.00) 2.67 (1.12) −5.38** 
Wisconsin card sorting testb       
 Perseverative errors 86.2 (9.9) 104.2 (11.8) −5.75** 
 Non-perseverative errors 84.0 (16.4) 94.0 (17.8) −2.02* 
 Conceptual level responses 82.6 (11.6) 99.0 (15.9) −4.12** 
 Categories complete 2.58 (1.50) 4.48 (1.78) −4.02** 
California verbal learning test-children's versionc       
 List A1-5 recall −1.00 (0.99) 0.59 (0.86) −6.11** 
 List A1 recall −0.83 (1.36) 0.74 (1.00) −4.66** 
 Short delay free recall −0.85 (1.16) 0.54 (0.97) −4.62** 
 Short delay cued recall −1.15 (1.19) 0.36 (1.06) −4.80** 
 Long delay free recall −1.15 (1.38) 0.44 (0.83) −4.96** 
 Long delay cued recall −1.04 (1.32) 0.48 (0.96) −4.68** 
 Serial clustering −0.54 (0.88) −0.32 (0.89) −0.88, n.s. 
 Semantic clustering −0.02 (1.12) −0.06 (0.70) −0.72, n.s. 
 Recognition −1.80 (2.19) 0.16 (0.81) −4.39** 
 
 a Scores reported as d′. 
 b Scores reported as standard scores. 
 s Scores reported as z scores. 
 * P < 0.05. 
** P < 0.001. 
 
Intellectual Ability and Achievement 
Table III displays means and standard deviations for the groups on the WISC-III. The control 
group scored significantly higher than the 22q11DS group on all intelligence variables including 
Full Scale IQ, Verbal IQ, Performance IQ, the four factor scores, and all subtests. Neither group 
exhibited a significant difference between Verbal IQ and Performance IQ, although at the 
individual level 20% of the 22q11DS participants and 29% of controls did so. Table IV presents 
means and standard deviations for the groups on the WIAT-II measure of academic achievement. 
The control group scored significantly higher on the Broad Mathematics Cluster, Broad Reading 
Cluster, and the spelling subtest. 
 
Table III. WISC-III Means and Standard Deviations by Group 
 
 
  22q11DS (n = 26) Control (n = 25) t-test 
  
Scale scores       
 Full scale IQ 70.7 (12.4) 108.9 (13.0) −10.44* 
 Verbal IQ 74.0 (12.3) 108.8 (12.2) −9.96* 
 Performance IQ 72.0 (12.9) 107.3 (13.8) −9.35* 
Factor scores       
 Verbal comprehension 75.8 (12.69) 108.2 (12.6) −8.81* 
 Perceptual organization 71.2 (13.4) 107.9 (14.2) −9.19* 
 Freedom from distractibility 77.4 (14.0) 106.1 (13.5) −6.86* 
 Processing speed 81.2 (15.9) 104.4 (14.9) −4.91* 
 
Table IV. WIAT-II Means and Standard Deviations by Group 
 
 
 
22q11DS (n = 26) Control (n = 25) t-test 
  
Broad reading 82.3 (17.5) 97.2 (17.4) −3.01* 
 Word reading 85.2 (15.3) 98.2 (13.9) −3.05* 
 Reading comprehension 79.2 (18.7) 99.4 (17.8) −3.86** 
 Pseudoword decoding 90.4 (16.9) 95.8 (17.0) −0.99, n.s. 
Broad mathematics 72.4 (16.0) 106.5 (14.6) −7.84** 
 Math reasoning 74.8 (15.3) 108.3 (13.2) −8.36** 
 Numerical operations 75.5 (17.8) 103.0 (14.0) −6.04** 
 Spelling 82.3 (16.0) 97.1 (12.6) −3.61* 
 
 * P < 0.01. 
** P < 0.001. 
In order to examine group differences between Full Scale IQ and achievement scores within the 
22q11DS group, mean group achievement scores were subtracted from the mean group Full 
Scale IQ. Differences between IQ and achievement scores are often examined to assess learning 
disabilities. Learning disabilities are often identified by Full Scale IQ scores that are at least 15 
point higher than achievement scores [Sattler, 2001], suggesting that a person is achieving at a 
lower level than would be expected based on intellectual ability. Neither group exhibited 
significant differences between IQ and achievement scores; however, at the individual level, two 
22q11DS participants (8%) and 12 control participants (48%) exhibited learning disabilities. 
Learning disabilities were found in both reading and mathematics domains in the two groups of 
participants. 
 
Childhood Psychological Disorders 
DSM-IV diagnoses were based on the C-DISC interviews conducted with each child's parent or 
guardian. Significantly more participants met criteria for diagnosis in the 22q11DS group (62%) 
than in the control group (32%), Fisher's exact test <0.05. Forty-six percent of the 22q11DS 
participants and 8% of the control participants met criteria for an anxiety disorder, Fisher's exact 
test <0.01. The rate of AD/HD diagnoses was 35% in the 22q11DS group and 24% in the control 
group, although this difference did not reach statistical significance, Fisher's exact test = 0.54. 
Likewise, the groups did not differ on the number of inattention or hyperactivity symptoms 
reported. No significant differences were found between the groups in terms of depressive 
pathology. Nine percent of the 22q11DS participants met criteria for Major Depression or 
Depression NOS, while none of the control participants met criteria for a depressive disorder, 
Fisher's exact test = 0.49. Despite the overall group differences in clinical diagnoses, there were 
no significant differences between the groups in terms of percentages of participants receiving 
mental health treatment (22q11DS group = 30%; control group = 28%). The groups differed on 
ratings of Global Assessment of Functioning [Endicott et al., 1976], with control participants 
functioning significantly better overall. None of the participants met criteria for a current or past 
psychotic disorder. 
 
Relationship of Neurocognitive Functioning With IQ and Psychopathology 
In order to account for the possible effect of general intellectual ability on the differences in 
neurocognitive performance, regression analyses were run partialling out variance associated 
with Verbal IQ and Performance IQ at the first step, and then entering group membership in at 
the second step. The effects of group over-and-above the effects of IQ were indicated by the 
semi-partial r2 (or change in R2) at step 2 (see Table V). Group membership continued to account 
for a significant portion of the variance on the CPT-IP and AX conditions. In terms of executive 
functioning, group membership continued to explain a significant portion of the variance on the 
Perseverative Errors index after including IQ in the model. After including IQ, group 
membership did not contribute significantly to the model in terms of any of the CVLT-C indices. 
 
 
Table V. Neurocognitive Measures and Intelligence 
  R2 step 1 (VIQ, PIQ) Change in R2 step 2 (group) 
  
Continuous performance test     
 IP version 0.273** 0.130** 
 AX version 0.358*** 0.060* 
Wisconsin card sorting test     
 Perseverative errors 0.317*** 0.111** 
 Non-perseverative errors 0.065 0.035 
 Conceptual level responses 0.235** 0.054† 
 
Anxiety and inattention may contribute to diminished performance on many of the measures 
administered in the present study. To determine whether anxiety disorder diagnosis affected 
neurocognitive performance, regression analyses were computed entering anxiety disorders at 
the first step and group membership at the next step (see Table VI). Group membership 
contributed significantly to the model after the effect of anxiety disorder diagnosis was partialled 
out for all neurocognitive indices except WCST non-perseverative errors. Additionally, anxiety 
disorders did not contribute significantly to the model on any of the neurocognitive measures 
except WCST non-perseverative errors. The same method was exacted using AD/HD inattention 
and hyperactivity symptoms at the first step. Group membership continued to contribute 
significantly to the model for all neurocognitive indices except WCST non-perseverative errors. 
There were no differences between our groups in terms of depression and the rates were very 
low, so comparable analyses partialing depression were not conducted. However, if differences 
in depressive pathology emerge in future assessments of this sample, the effects of these 
symptoms on cognitive performance need to be examined. 
 
Table VI. Neurocognitive Measures, Anxiety, and AD/HD 
 Categories complete 0.238** 0.059† 
California verbal learning test-children's version     
 List A1-5 recall 0.629*** 0.002 
 List A1 recall 0.414*** 0.000 
 Short delay free recall 0.455*** 0.000 
 Short delay cued recall 0.529*** 0.006 
 Long delay free recall 0.463*** 0.000 
 Long delay cued recall 0.530*** 0.010 
 Recognition 0.525*** 0.031 
 
 * P < 0.05. 
 ** P < 0.01. 
 **, *** P < 0.001. 
† P < 0.10. 
 
 
  R2 step 1 (anxiety) Change in R2 step 2 (group) 
  
Continuous performance test     
 IP version 0.066† 0.274*** 
 AX version 0.051 0.331*** 
Wisconsin card sorting test     
 Perseverative errors 0.064† 0.349*** 
 Non-perseverative errors 0.088* 0.033 
 Conceptual level responses 0.068† 0.202** 
 Categories complete 0.072† 0.190** 
California verbal learning test-children's version     
 List A1-5 recall 0.025 0.426*** 
 List A1 recall 0.010 0.321*** 
 Short delay free recall 0.021 0.292*** 
 Short delay cued recall 0.035 0.288*** 
 Long delay free recall 0.008 0.357*** 
 Long delay cued recall 0.042 0.268*** 
 Recognition 0.035 0.305*** 
  R2 step 1 (AD/HD symptoms) Change in R2 step 2 (group) 
Continuous performance test     
 IP version 0.070 0.295*** 
 AX version 0.044 0.361*** 
Wisconsin card sorting test     
 Perseverative errors 0.032 0.390*** 
 Non-perseverative errors 0.060 0.062† 
 Conceptual level responses 0.072 0.230*** 
 Categories complete 0.066 0.221** 
California verbal learning test-children's version     
 List A1-5 recall 0.039 0.406*** 
 List A1 recall 0.031 0.291*** 
 Short delay free recall 0.006 0.297*** 
 
DISCUSSION 
The present study examined neurocognitive deficits often seen in schizophrenia patients and at-
risk samples in children and adolescents with 22q11DS. This design follows a long tradition of 
research conducted with groups presumed to be at genetic high risk for psychiatric disorders who 
have not yet manifested full-blown psychiatric symptoms [e.g., Erlenmeyer-Kimling, 2000]. 
Additionally, the rate of psychosis reported in adults with 22q11DS (25–30%) is substantially 
higher than the rate of psychosis reported in offspring of biological parents with schizophrenia 
(∼10%), who have represented a common paradigm for genetic high-risk samples, suggesting 
that the present population is especially promising for this type of work. We believe that this is 
the first study to specifically report that schizophrenic-like neurocognitive deficits are more 
pronounced relative to intellectual functioning in non-psychotic participants with 22q11DS than 
control participants. 
 
Neurocognitive Functioning 
As hypothesized, the 22q11DS group performed significantly worse on measures of sustained 
attention, executive functioning, and verbal memory as compared to controls, and many of these 
findings remained even after accounting for the effects of Verbal and Performance IQ. These 
findings are consistent with previous reports of deficits in patients with schizophrenia and their 
first degree relatives, suggesting that these deficits appear prior to decompensation during 
premorbid and prodromal stages of illness [Nuechterlein, 1983; Cornblatt and Erlenmeyer-
Kimling, 1985]. 
 Short delay cued recall 0.022 0.309*** 
 Long delay free recall 0.045 0.305*** 
 Long delay cued recall 0.007 0.308*** 
 Recognition 0.040 0.325*** 
 
 * P < 0.05. 
 ** P < 0.01. 
 *** P < 0.001. 
† P < 0.010. 
 
 
The present findings indicate that children with 22q11DS exhibit deficits in sustained attention, 
and that these difficulties are over and above what would be expected based on general deficit in 
IQ. Cornblatt et al. [1988] reported that the CPT version used in the present investigation was 
successful at detecting attention deficits in unaffected, at-risk offspring of persons with 
schizophrenia, and that it was an effective predictor of the subsequent development of 
schizophrenia. 
In terms of executive functioning, results from the WCST indicate that participants with 
22q11DS made more matching mistakes than controls and had a higher rate of perseveration, or 
continued use of the same sorting strategy even when it ceased being effective. Further, 
participants with 22q11DS scored lower on Conceptual Level Responses, which indicates a 
participant's understanding of the task by calculating strings of correct matches. Perseverative 
Errors continued to account for a significant portion of variance between groups after the effects 
of IQ were taken into account, indicating that the results are robust against small sample size and 
independent of the effects of IQ. These findings are consistent with numerous reports that 
patients with schizophrenia show impairments on the WCST compared to controls [e.g., Gold 
and Harvey, 1993; Aloia et al., 1996]. Furthermore, individuals psychometrically identified as at-
risk for schizophrenia and offspring of schizophrenia patients show increased rates of 
perseverative errors on the WCST [Lenzenweger and Korfine, 1994; Gooding et al., 1999; 
Diforio et al., 2000; Diwadkar et al., 2006]. The present findings, together with previous 
investigations of executive functioning using the WCST, suggest that poor performance on this 
measure is a promising marker of risk for schizophrenia and spectrum disorders. 
As was hypothesized, data from the CVLT-C indicated that participants with 22q11DS 
performed significantly worse than controls on recall indices. Additionally, the 22q11DS group 
scored significantly lower on the recognition task, indicating that these participants may have 
had difficulty at the encoding level. Verbal memory and verbal learning deficits have been 
reported in persons with schizophrenia and schizotypal personality disorder [Saykin et al., 1991; 
Bergman et al., 1998], as well as in the first-degree relatives of schizophrenic patients and non-
psychotic adolescents identified as schizotypic, suggesting a link between verbal memory 
deficits and liability for schizophrenia [Lyons et al., 1995; Barrantes-Vidal et al., 1999]. 
Furthermore, findings suggest that patients with schizophrenia may experience encoding deficits, 
and that recall deficits stemming from encoding problems may be related to disorganization 
[Calev et al., 1983; Levin et al., 1989; Lyons et al., 1995]. The present data suggest that persons 
with 22q11DS experience schizophrenic-like deficits in encoding, evidencing significantly 
poorer discriminability on the recognition task. However, the regression findings suggest that the 
22q11DS participants' deficits on verbal learning and memory were not worse than would be 
expected given their impaired intellectual abilities, which is consistent with the hypothesis that 
22q11DS patients have relative strengths in verbal abilities compared to non-verbal abilities. 
In terms of memory strategies, the CVLT-C allows comparisons between serial clustering and 
semantic clustering. It is believed that semantic clustering represents a more advanced learning 
strategy, as it requires on-line processing as well as the manipulation of items in memory. It was 
expected based on lower levels of cognitive and verbal ability in persons with 22q11DS and past 
findings [Lyons et al.,1995] that control participants would use significantly more semantic 
clustering than the 22q11DS participants. However, the data did not support this expectation, 
showing non-significant differences between groups in terms of strategy use. 
The present findings indicate that children and adolescents with 22q11DS exhibit deficits in 
cognitive functioning compared to control participants, and that deficits in attention and 
executive functioning exceed the levels that would be expected based on general intellectual 
functioning. These findings support previous reports of cognitive impairment in children with 
22q11DS, as well as findings that these children tend to exhibit non-verbal learning deficits, as 
verbal learning deficits did not exceed the level that would be expected based on intellectual 
ability. Furthermore, the present study extends these findings by demonstrating the presence of 
pronounced cognitive impairment in attention and executive functioning relative to general 
intellectual functioning—domains in which patients with schizophrenia and people identified as 
at-risk show cognitive deficits. 
Frontal lobe functioning 
The CPT-IP, WCST, and CVLT-C assess attention, executive functioning, and working 
memory—higher-order cognitive processes that are mediated by the frontal lobes. 
Neurocognitive deficits seen in schizophrenic patients likely represent indicators of dysfunction 
of neuronal circuits, specifically those involved in frontal lobe functioning [Fuster, 1991, 1999; 
Cummings, 1995; Knight et al., 1995; Smith and Jonides, 1999; Weinberger et al., 2001; Kane 
and Engle, 2002; Tekin and Cummings, 2002]. In their meta-analysis examining brain-imaging 
studies, Davidson and Heinrichs [2003] found that the strongest group differences between 
schizophrenic patients and controls involved hypofrontality, or reduced frontal lobe metabolism 
or blood flow activity during cognitive tasks mediated by this region. The present findings of 
schizophrenic-like neurocognitive deficits in non-psychotic children and adolescents with 
22q11DS support the examination of specific cognitive deficits as markers of risk for 
schizophrenia, and suggest an underlying deficit in prefrontal functioning in individuals who are 
at-risk. 
 
General Cognitive Profile 
The present data support previous findings regarding average IQ scores in persons with 22q11DS 
[e.g., Swillen et al., 2000], as this sample scored significantly below the controls and the 
normative mean with an average Full Scale IQ of 70.7. However, the present data did not support 
increased levels of learning disabilities in persons with 22q11DS. The present sample of 
22q11DS children and adolescents was achieving at the level that would be expected based on 
Full Scale IQ scores in terms of mathematics, and was actually overachieving in the area of 
Broad Reading skills, with significant splits between Full Scale IQ and achievement favoring 
achievement. 
Although these data do not support increased levels of learning disabilities in persons with 
22q11DS, they do support previous findings that persons with 22q11DS show impairments 
resembling non-verbal learning deficits, with overall difficulties centering on mathematics and 
perceptual organization skills. Within the 22q11DS group, there was a small, non-significant 
difference between Verbal IQ and Performance IQ in favor of Verbal IQ, and the Perceptual 
Organization factor score was from 5 to 10 points lower than the other factor scores. Together 
with the achievement scores, these data support previous findings of patterns of cognitive 
impairment that resemble non-verbal learning deficits in persons with 22q11DS, but are 
inconsistent with an underlying language deficit as posited by Gerdes et al. [1999]. 
Children with 22q11DS may exhibit relatively small achievement deficits compared to their 
healthy peers while academic demands are relatively concrete. However, as demands become 
more abstract, children with 22q11DS experience increasing deficits relative to their classmates 
[Golding-Kushner et al., 1985]. Since the average level of education of children and adolescents 
in the present study is approximately 3 years, academic demands are likely at a concrete level. 
This may contribute to the relatively high level of academic achievement in the Broad Reading 
cluster in the present 22q11DS sample. As more data become available, evaluation of changes in 
cognitive functioning and academic achievement over time within the 22q11DS sample and as 
compared to controls will be possible, allowing further investigation into this finding. 
 
Childhood Psychopathology 
The rate of psychopathology in our control group was 32%, which, while seemingly high, 
appears to be consistent with epidemiological studies of the rate of psychopathology in children 
and adolescents [Fergussen et al., 1993; Kessler et al., 1994]. Furthermore, this rate fell within 
the range reported by Roberts et al. [1998] in their review of studies of the overall prevalence of 
childhood and adolescent disorders. While rates of psychopathology were significantly higher in 
the 22q11DS group than the control group, the groups did not differ significantly on rates of 
mental health treatment. One possibility for this concerning finding is that, given the 
constellation of medical difficulties that often accompany 22q11DS, as well as intellectual 
deficits and subsequent educational challenges faced by these children and their families, 
treatment for symptoms of psychopathology may seem less urgent in terms of services. Another 
possibility is that anxiety symptoms, the most commonly reported symptoms in our 22q11DS 
sample, may seem like appropriate or understandable responses to medical difficulties, frequent 
medical appointments and procedures, and other difficulties faced by these children, and not 
viewed as separate disorders requiring services. Nevertheless, this finding is obviously 
concerning given the large proportion of participants who have experienced psychopathology in 
childhood and the significant risk of severe psychopathology in adulthood. These findings speak 
to the need to improve awareness of mental health issues in 22q11DS, as well over half of all 
children in our sample met criteria for a psychological disorder. Children with 22q11DS may 
benefit from psychological assessment to determine the appropriateness of mental health 
services, which should target current symptoms and consider prophylactic interventions to 
decrease the likelihood of schizophrenia and related disorders in late adolescence and early 
adulthood. Further investigation of childhood psychopathology in 22q11DS and risk for 
continued difficulties and later development of severe psychopathology is certainly warranted, 
including the examination of group differences in depression, especially as the participants enter 
adolescence. 
 
Support for a Neurodevelopmental Model of Schizophrenia 
Taken together, the present data support the presence of neurocognitive deficits in persons 
identified as at-risk for the development of schizophrenia based on a known genetic marker. 
These data are consistent with a neurodevelopmental model of schizophrenia, demonstrating the 
presence of deficits commonly found in persons who have decompensated into schizophrenia in 
a non-psychotic sample presumed to be at risk. Neural dysmaturation during development may 
lead to cognitive and biobehavioral impairments, many of which would be expected to manifest 
prior to the development of more traditional symptoms of the disorder [Andreasen, 1999]. These 
deficits may represent specific areas of neural dysmaturation common in schizophrenia, or may 
represent increased liability in and of themselves [Gooding and Iacono, 1995]. Future work will 
permit investigation of the predictive value of premorbid cognitive performance and other 
behavioral, genetic, and neural measures for psychiatric outcome. Prospective studies will 
attempt to examine the precise relationships among these deficits, 22q11DS, and specific risk for 
schizophrenia. 
The present findings support the examination of cognitive functioning as an endophenotype in 
keeping with descriptions by Gottesman and Gould [2003] (for schizophrenia) and Waldman 
[2005] (for Attention-Deficit/Hyperactivity Disorder). Specifically, cognitive processes that 
involve frontal lobe-mediated working memory and executive functioning may represent a 
distinct heritable dimension in schizophrenia [Cannon, 2005]. Endophenotypes are hypothesized 
to offer more immediate links to candidate genes than fully expressed clinical disorders, and may 
have utility in examining genetic inheritance, especially in complex diseases in which there may 
be multiple heritable dimensions [Cannon, 2005]. Thus, endophenotypes are presumed to 
provide a neurodevelopmental link between genes and manifest disorders. 
Children with 22q11DS exhibit an array of cognitive, behavioral, and psychiatric difficulties that 
may have implications for later psychiatric outcome and adjustment. Identification of features 
that precede the onset of clinical symptoms is important in understanding the 
neurodevelopmental processes that contribute to later adjustment, as well as the development of 
early intervention strategies [Murphy,2005]. While the present study provides evidence for 
schizophrenic-like deficits in children and adolescents with 22q11DS, substantial heterogeneity 
of symptoms exists among individuals with this syndrome, indicating that further identification 
of specific risk markers for the development of psychosis in this population is needed. Continued 
investigation of this population, including studies of premorbid and prodromal symptoms and 
areas of dysfunction, may help refine our understanding of the etiological pathway(s) of 
schizophrenia, as well as clarify factors that further contribute to risk. Such an understanding 
may increase accuracy in identification of persons at risk, improving the effectiveness of 
prophylactic treatment efforts. 
The goal of the present study was to test for hypothesized group differences in a cross-sectional 
design. This is a logical starting place for validating the hypothesis that non-psychotic 
individuals believed to be at risk for schizophrenia will demonstrate schizophrenic-like 
deficits—a common focus in the schizotypy literature. The present study was not an assessment 
of criterion validity, nor did it offer predictions about which participants will develop spectrum 
disorders. Such questions fall in the domain of individual differences and require longitudinal 
assessment. We hope to conduct longitudinal research with this sample that will allow for the 
measurement of individual trajectories within our at-risk group. However, a necessary precursor 
to longitudinal study is to establish baseline measures in the domains of interest and examine 
group differences. 
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